900
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study

, , , , , , , , , , , , , , , & show all
Article: 2238186 | Received 18 Apr 2023, Accepted 14 Jul 2023, Published online: 21 Jul 2023

References

  • Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008;148(5):1–10. doi: 10.7326/0003–4819–148–5-200803040–00003.
  • Liang Q, Pang Y, Yang Y, et al. An improved algorithm for rapid diagnosis of pleural tuberculosis from pleural effusion by combined testing with GeneXpert MTB/RIF and an anti-LAM antibody-based assay. BMC Infect Dis. 2019;19(1):548. doi: 10.1186/s12879–019–4166–1.
  • Nicol MP, Schumacher SG, Workman L, et al. Accuracy of a novel urine test, fujifilm SILVAMP tuberculosis lipoarabinomannan, for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis. 2021;72(9):e280–288–e288. doi: 10.1093/cid/ciaa1052.
  • Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84. doi: 10.1016/S1473–3099(17)30691–6.
  • Penn-Nicholson A, Georghiou SB, Ciobanu N, et al. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study. Lancet Infect Dis. 2022;22(2):242–249. doi: 10.1016/S1473–3099(21)00452–7.
  • Penn-Nicholson A, Gomathi SN, Ugarte-Gil C, et al. A prospective multicentre diagnostic accuracy study for the truenat tuberculosis assays. Eur Respir J. 2021;58(5):2100526. doi: 10.1183/13993003.00526–2021.
  • Ivanyi J. Serodiagnosis of tuberculosis: due to shift track. Tuberculosis (Edinb). 2012;92(1):31–37. doi: 10.1016/j.tube.2011.09.001.
  • García-Basteiro AL, Cobelens F. Triage tests: a new priority for tuberculosis diagnostics. Lancet Respir Med. 2015;3(3):177–178. doi: 10.1016/S2213–2600(15)00061–2.
  • Morris K. WHO recommends against inaccurate tuberculosis tests. Lancet. 2011;377(9760):113–114. doi: 10.1016/s0140–6736(11)60005–6.
  • Blakemore R, Nabeta P, Davidow AL, et al. A multisite assessment of the quantitative capabilities of the xpert MTB/RIF assay. Am J Respir Crit Care Med. 2011;184(9):1076–1084. doi: 10.1164/rccm.201103–0536OC.
  • Cohen KA, El-Hay T, Wyres KL, et al. Paradoxical hypersusceptibility of drug-resistant Mycobacterium tuberculosis to β-lactam antibiotics. EBioMedicine. 2016;9:170–179. doi: 10.1016/j.ebiom.2016.05.041.
  • Whitworth HS, Badhan A, Boakye AA, et al. Clinical utility of existing and second-generation interferon-gamma release assays for diagnostic evaluation of tuberculosis: an observational cohort study. Lancet Infect Dis. 2019;19(2):193–202. doi: 10.1016/S1473–3099(18)30613–3.
  • Wu X, Yang Y, Zhang J, et al. Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis. Clin Chim Acta. 2010;411(19–20):1520–1528. doi: 10.1016/j.cca.2010.06.014.
  • Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis. 2000;80(3):131–140. doi: 10.1054/tuld.2000.0243.
  • Comella-del-Barrio P, Molina-Moya B, Gautier J, et al. Diagnostic performance of the fujifilm SILVAMP TB-LAM in children with presumptive tuberculosis. J Clin Med. 2021;10:1914. doi: 10.3390/jcm10091914.
  • Gennaro ML. Immunologic diagnosis of tuberculosis. Clin Infect Dis. 2000;30(Suppl 3):S243–S6. doi: 10.1086/313868.
  • Hao X, Bai J, Ding Y, et al. Characterization of antibody response against 16kD and 38kD of M. tuberculosis in the assisted diagnosis of active pulmonary tuberculosis. Ann Transl Med. 2020;8(15):945. doi: 10.21037/atm-20–5476.
  • Hu Y, Liu M, Hu H, et al. Accuracy of multitarget indirect enzyme-linked immunoassay assay for detection of tuberculosis antibody. Ann Transl Med. 2021;9(23):1731. doi: 10.21037/atm-21–5598.
  • Wang S, Wu J, Chen J, et al. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection. Int J Infect Dis. 2018;70:1–9. doi: 10.1016/j.ijid.2018.01.007.
  • Adams S, Ehrlich R, Baatjies R, et al. Predictors of discordant latent tuberculosis infection test results amongst South african health care workers. BMC Infect Dis. 2019;19(1):131. doi: 10.1186/s12879–019–3745–5.
  • Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–1259. doi: 10.1016/S0140–6736(17)32154–2.
  • Esmail H, Riou C, Bruyn ED, et al. The immune response to Mycobacterium tuberculosis in HIV-1-coinfected ­persons. Annu Rev Immunol. 2018;36:603–638. doi: 10.1146/annurev-immunol-042617–053420.
  • Scriba TJ, Tameris M, Smit E, et al. A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis infected adults. Am J Respir Crit Care Med. 2012;185(7):769–778. doi: 10.1164/rccm.201108–1548OC.